Momenta Pharmaceuticals, Inc.
(NASDAQ : MNTA)

( )
MNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.95%171.301.3%$495.18m
BIIBBiogen Inc.
0.91%235.041.3%$480.36m
CELGCelgene Corporation
0.11%96.361.3%$457.23m
GILDGilead Sciences, Inc.
-0.03%66.500.9%$434.72m
ILMNIllumina, Inc.
2.08%312.833.5%$317.70m
REGNRegeneron Pharmaceuticals, Inc.
3.27%320.092.6%$298.61m
AAgilent Technologies, Inc.
-0.50%67.981.6%$207.68m
VRTXVertex Pharmaceuticals Incorporated
1.92%172.371.9%$181.17m
EXASExact Sciences Corporation
-2.10%94.9125.3%$163.66m
ALXNAlexion Pharmaceuticals, Inc.
-0.97%127.552.0%$149.64m
BMRNBioMarin Pharmaceutical Inc.
0.25%87.694.3%$118.55m
SRPTSarepta Therapeutics, Inc.
0.36%121.6214.7%$112.14m
INCYIncyte Corporation
0.43%79.022.5%$105.72m
IONSIonis Pharmaceuticals, Inc.
-0.98%68.568.2%$98.74m
ALNYAlnylam Pharmaceuticals, Inc
-0.09%67.819.2%$94.94m

Company Profile

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.